Coherus Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.About CHRS
Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.
CHRS Key Statistics
Stock Snapshot
As of today, Coherus Oncology(CHRS) shares are valued at $1.66. The company's market cap stands at 250.32M, with a P/E ratio of -1.12.
On 2026-03-16, Coherus Oncology(CHRS) stock traded between a low of $1.63 and a high of $1.70. Shares are currently priced at $1.66, which is +2.2% above the low and -2.4% below the high.
The Coherus Oncology(CHRS)'s current trading volume is 836.22K, compared to an average daily volume of 1.61M.
During the past year, Coherus Oncology(CHRS) stock moved between $0.71 at its lowest and $2.62 at its peak.
During the past year, Coherus Oncology(CHRS) stock moved between $0.71 at its lowest and $2.62 at its peak.
CHRS News
Analyst Douglas Tsao of H.C. Wainwright reiterated a Buy rating on Coherus Biosciences, retaining the price target of $7.00. Claim 70% Off TipRanks Premium Unlo...
Analyst ratings
83%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.